Marcus A. Banks

Marcus A. Banks

Marcus is a science and health journalist based in New York City. He graduated from the Science Health and Environmental Reporting Program at New York University in 2019, and earned a master’s in Library and Information Science from Dominican University in 2002. He’s written for Slate, Undark, Spectrum, and Cancer Today.

Articles by Marcus A. Banks
Cones Derived from Human Stem Cells Help Mice See: Study
Cones Derived from Human Stem Cells Help Mice See: Study
Marcus A. Banks | Apr 23, 2021
Researchers insert functioning cone photoreceptors into the retinas of mice with advanced eye disease, improving their vision.
Cancer Cells Could Travel Through the Interstitium: Study
Cancer Cells Could Travel Through the Interstitium: Study
Marcus A. Banks | Apr 19, 2021
The continuous network of fluid-filled compartments crosses organ barriers and might serve as a conduit for tumor cells to spread.
Cerebellum Plays Crucial Role in Metabolizing Alcohol in Mice
Cerebellum Plays Crucial Role in Metabolizing Alcohol in Mice
Marcus A. Banks | Mar 31, 2021
The researchers say these findings challenge dogma in the field, which has given the liver all credit for metabolizing alcohol.
Researchers Develop Standards for Reporting Polygenic Risk Scores
Researchers Develop Standards for Reporting Polygenic Risk Scores
Marcus A. Banks | Mar 17, 2021
Current reporting about the contribution of genetic variations to a person’s risk of disease is often incomplete and hard to interpret, according to the authors of a set of best practices for presenting such information.
Some Children with COVID-19 or MIS-C Face Kidney Injury: Study
Some Children with COVID-19 or MIS-C Face Kidney Injury: Study
Marcus A. Banks | Mar 10, 2021
The link between SARS-CoV-2 and potential stress to kidneys is unclear, but damage to the organs has been documented in adults with COVID-19 too.
NIH Halts Outpatient COVID-19 Convalescent Plasma Trial
NIH Halts Outpatient COVID-19 Convalescent Plasma Trial
Marcus A. Banks | Mar 4, 2021
The decision adds to evidence that the benefits of plasma infusions from COVID-19 survivors may be limited, but advocates say the case isn’t closed.
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Regeneron Cocktail Stumbles Against SARS-CoV-2 Variant in Vitro
Marcus A. Banks | Mar 1, 2021
A treatment of two monoclonal antibodies against SARS-CoV-2 is ninefold less effective in the lab against the B.1.351 variant than against the dominant version of the virus.
COVID-19 More Deadly with Blood than Solid Cancer: Study
COVID-19 More Deadly with Blood than Solid Cancer: Study
Marcus A. Banks | Feb 16, 2021
Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.